论文部分内容阅读
Objective:To study the effect of immunotherapy combined with epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) drug therapy on the tumor malignancy in patients with EGFR-mutant advanced non-small cell lung cancer (NSCLC).Methods:Pati